MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Canadian Journal of Health Technologies
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

660 results · 1 filter active ·
Results by year
20212025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
660 works in the cohort · of 4,299,418page 3 of 14

Labels cover 1 of 660 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 660 of 660 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Somatrogon (Ngenla)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Artificial Intelligence for Patient Flow
CADTH
2024· article· en· Canadian Journal of Health Technologies· Health Professions
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Semaglutide for Type 2 Diabetes (2 mg)
Deepa Jahagirdar, Quenby Mahood
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Larotrectinib (Vitrakvi)
Reimbursement Team
2021· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Tucatinib (Tukysa)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Mepolizumab (Nucala)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Pemigatinib (Pemazyre)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Glofitamab (Columvi)
CADTH
2024· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Daratumumab (Darzalex SC)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Emerging Drugs for Amyotrophic Lateral Sclerosis
Michel Boucher, Monika Mierzwinski‐Urban
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Selumetinib (Koselugo)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Olaparib (Lynparza)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Treatment Programs for Substance Use Disorder
Khai Tran, Sarah McGill
2021· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Lebrikizumab (Ebglyss)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Belzutifan (Welireg)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Etrasimod (Velsipity)
CDA-AMC
2024· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Guselkumab (Tremfya)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Fruquintinib (Fruzaqla)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Avacopan (Tavneos)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Faricimab (Vabysmo)
CADTH
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Delayed Tuberculin Skin Testing
Anusree Subramonian, Melissa Walter
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Zanubrutinib (Brukinsa)
Reimbursement Team
2022· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Andexanet Alfa (Ondexxya)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Polatuzumab Vedotin (Polivy)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Setmelanotide (Imcivree)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Biologics in Plaque Psoriasis
Peter Dyrda, Sirjana Pant
2021· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Pembrolizumab (Keytruda)
CDA-AMC
2025· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
aboutno affunlabeled
Lurbinectedin (Zepzelca)
CADTH
2023· article· en· Canadian Journal of Health Technologies· Medicine
distilled prediction:candidate · noneconsensus · none
1
citations
← previousnext →

How this was built: Screen · Findings · About